Professor Patrick Thornton, Hon. Professor RCSI, Chairman Haematology DSSG Cancer Trials Ireland; Clinical Director Hermitage Medical Clinic Laboratory discusses Chronic Lymphocytic Leukaemia (CLL), gives an update on the status of new therapies in Ireland, and shares exciting news of upcoming clinical trials that patients in Ireland will be able to benefit from.
This video was recorded at the 2019 CLL Ireland Information Day held in Dublin, Ireland on 8 June 2019.
From caregiver, to CLL Blood Cancer patient and return to health following CAR-T treatment.
The CLL Society’s Dr Brian Koffman shares his journey with CLL, his experience following his participation in a clinical trial for CAR-T (Chimeric Antigen Receptor Therapy) while Patty Koffman, Brian’s wife and Executive Director of the CLL Society, explains CAR-T through animation.
This presentation was recorded at the 2019 CLL Ireland Information Day held in Dublin, Ireland, on 8 June 2019.
Dr. Brian Koffman (CLL Society, USA), Nick York (Leukaemia Care, UK) and Michael Rynne (CLL Ireland) explain the basic terms and concepts behind CLL.
This presentation was recorded at the 2019 CLL Ireland Information Day held in Dublin, Ireland, on 8 June 2019.
Louise O’Driscoll, Clinical Psychologist, St. Vincent’s Hospital Dublin discusses how CLL patients can help deal with the psychological impact of their blood cancer diagnosis and gives practical advice to those who are supporting those living with cancer.
This video was recorded at the CLL Ireland ‘Stormy Minds Can Be Calmed’ Evening of Support held in Mullingar, Ireland on 19 October 2018.
Prof. Peter Hillmen, Professor of Experimental Haematology & Honorary Consultant Hematologist, Leeds Teaching Hospitals NHS Trust discusses…
What’s significant in CLL now;
New therapies in the treatment of CLL;
and gives an overview on Clinical trials for the treatment of CLL.
This video was recorded at the 2018 CLL Ireland Information Day held in Dublin, Ireland on 5 May 2018.
Professor Patrick Thornton, Consultant Haematologist, Senior Lecturer RCSI, and Clinical Director Hermitage Medical Clinic Laboratory gives an update on Venetoclax for the treatment of CLL and the issues patients in Ireland are having accessing this novel agent.
Professor Peter Hillmen talks about Minimal Residual Disease (MRD) and why MRD is an important predictor for response to treatment for CLL patients. He also discusses advances in the treatment of CLL and what the next 5 years might bring.
Professor Patrick Thornton, Consultant Haematologist, Senior Lecturer RCSI & Clinical Director Hermitage Medical Clinic Laboratory discusses Chronic Lymphocytic Leukaemia (CLL) and an update on the status of new therapies in Ireland.
This video was recorded at the 2018 CLL Ireland Information Day held in Dublin, Ireland on 5 May 2018.
Dr. Robert O’Connor discusses the difficulties in securing access to new treatments and the opportunities for advocacy groups and patients to engage with politicians and the National Centre for Pharmacoeconomics in trying to help get new treatments available for CLL patients in Ireland.
This interview was recorded at the CLL Ireland Information Day 2018 held in Dublin, Ireland, on 5 May 2018.